We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLKN icon
426
MillerKnoll
MLKN
$1.53B
$4.42M 0.02%
106,271
-4,292
-4% -$199K
MPLX icon
427
MPLX
MPLX
$59.6B
$4.42M 0.02%
173,828
VV icon
428
Vanguard Large-Cap ETF
VV
$51.7B
$4.42M 0.02%
29,926
-220
-0.7% -$31.1K
AGCO icon
429
AGCO
AGCO
$8.55B
$4.42M 0.02%
57,262
+28
+0% +$2.15K
NOW icon
430
ServiceNow
NOW
$111B
$4.37M 0.02%
77,365
+34,825
+82% +$1.83M
INTU icon
431
Intuit
INTU
$84.2B
$4.34M 0.02%
16,569
+124
+0.8% +$32.4K
RIO icon
432
Rio Tinto
RIO
$148B
$4.3M 0.02%
72,458
-667
-0.9% -$36.2K
ZBH icon
433
Zimmer Biomet
ZBH
$18B
$4.27M 0.02%
29,385
+926
+3% +$128K
HEFA icon
434
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.48B
$4.26M 0.02%
139,816
+1,564
+1% +$47.7K
PAA icon
435
Plains All American Pipeline
PAA
$17.2B
$4.22M 0.02%
229,744
+2,154
+0.9% +$39.6K
MITSY
436
DELISTED
MITSUI & CO LTD ADR (US)
MITSY
$4.22M 0.02%
11,784
+3
+0% +$1.07K
HPQ icon
437
HP
HPQ
$24B
$4.18M 0.02%
203,511
-193,960
-49% -$3.67M
VOYA icon
438
Voya Financial
VOYA
$8.91B
$4.11M 0.02%
67,467
+97
+0.1% +$5.47K
XIFR
439
XPLR Infrastructure LP
XIFR
$1.17B
$4.08M 0.02%
77,420
-425
-0.5% -$22.1K
BABA icon
440
Alibaba
BABA
$274B
$4.07M 0.02%
19,199
+37
+0.2% +$6.94K
FBIN icon
441
Fortune Brands Innovations
FBIN
$6.12B
$4.07M 0.02%
72,917
-5,074
-7% -$267K
BNY
442
Bank of New York Mellon
BNY
$107B
$4.04M 0.02%
80,310
-1,712
-2% -$81.7K
BTI icon
443
British American Tobacco
BTI
$131B
$4.01M 0.02%
94,419
+44,398
+89% +$1.67M
STT icon
444
State Street
STT
$50.1B
$4M 0.02%
50,648
+25,375
+100% +$1.79M
MEDP icon
445
Medpace
MEDP
$16.6B
$3.99M 0.02%
47,448
-1,318
-3% -$102K
ASML icon
446
ASML
ASML
$627B
$3.98M 0.02%
13,445
-464
-3% -$125K
IVW icon
447
iShares S&P 500 Growth ETF
IVW
$71.8B
$3.97M 0.02%
81,956
-3,752
-4% -$174K
SJM icon
448
J.M. Smucker
SJM
$12.9B
$3.96M 0.02%
38,039
-3,595
-9% -$381K
MMS icon
449
Maximus
MMS
$3.24B
$3.95M 0.02%
53,117
ING icon
450
ING
ING
$95.1B
$3.92M 0.02%
325,021
+137,669
+73% +$1.58M

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.